(81 days)
The Accu-Chek Complete System is intended for testing glucose by persons with diabetes or by health care professionals in the home or in health care facilities.
The Accu-Chek Complete Meter is an invitro device designed for measuring the concentrations of glucose in whole blood which is applied to Accu-Chek Advantage or Accu-Chek Advantage H Test Strips.
The provided 510(k) summary (K973662) for the Accu-Chek Complete Meter does not contain information about acceptance criteria or a study that proves the device meets those criteria.
This document primarily focuses on establishing substantial equivalence to a predicate device (Accu-Chek Advantage System) by comparing their intended use, operating principles, and various features. It lists similarities and differences between the new device and the predicate but does not present performance data or acceptance criteria for the Accu-Chek Complete Meter itself.
Therefore, I cannot fulfill your request for the specific information regarding acceptance criteria and study results based on the provided text. The document is a 510(k) summary, which often focuses on comparative aspects rather than detailed performance study reports.
{0}------------------------------------------------
K973662
Dec. 15, 1997
510(k) Summary
| Introduction | According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence. |
|---|---|
| 1) Submitter name, address, contact | Boehringer Mannheim Corporation9115 Hague Rd.Indianapolis, IN 46250(317) 845-2000Contact Person: Mike FlisDate Prepared: |
| 2) Device name | Proprietary name: Accu-Chek Complete MeterCommon name: Blood glucose test systemClassification name: glucose dehydrogenase, glucose |
| 3) Predicate device | We claim substantial equivalence to the Boehringer Mannheim Accu-Chek Advantage System. 510(k) files #K930979, #K951887, and #K954833. |
| 4) Device Description | The Accu-Chek Complete Meter is an invitro device designed for measuring the concentrations of glucose in whole blood which is applied to Accu-Chek Advantage or Accu-Chek Advantage H Test Strips. |
| Continued on next page |
{1}------------------------------------------------
510(k) Summary, Continued
The Accu-Chek Complete System is designed for testing glucose by persons 5) Intended use with diabetes or by health care professionals in the home or in health care facilities. The Boehringer Mannheim Accu-Chek Complete System is substantially 6) Comparison equivalent to other products in commercial distribution intended for similar to predicate use. Most notably it is substantially equivalent to the currently marketed device Accu-Chek Advantage System.
Continued on next page
{2}------------------------------------------------
510(k) Summary, Continued
(
(
| Similarities toPredicateDevice | Intended use [testing glucose in whole blood by persons with diabetes orby health care professionals in the home or health care facilities]Indicated for over-the-counter use with capillary blood samples only[Accu-Chek Advantage and Accu-Chek Advantage H Test Strips]Indicated for use with capillary, venous, arterial, and neonate bloodsamples by professionals (only applies to use with Accu-Chek H TestStrips) -- professional use with Accu-Chek Advantage Test Strips islimited to capillary blood samplesGlucose dehydrogenase or glucose oxidase test strip (test principle) isunchanged - meter will operate with either strip versionMeter operating procedure unchanged [The Advantage Test Stripemploys the electrochemical principle of biamperometry. The monitorapplies a voltage between two identical electrodes, the causes thereduced mediator formed during the test's incubation period to bereconverted to oxidized mediator. This generates a small current that isread by the meter.]Meter coding procedure unchangedTest strip dosing location remains outside the monitor -- meaning nostrip guide or monitor optics cleaning required. Meter cleaning [Dampcloth of 10% bleach solution] and troubleshooting proceduresunchanged.Meter storage condition limits unchanged [-13°F to 149°F, <95% RH]Meter operating condition limits unchanged [57°F to 104°F, <85% RH]Errors are depicted on LCD display and viaaudible beepsAll test strip and liquid controls related directions for use and claimsunchangedLimitations of procedure (including system measurement range)unchangedExpected results unchangedInstructions regarding response to unusual results unchangedWarnings and precautions unchangedResults referenced to whole blood laboratory testing unchangedContinued on next page |
|---|---|
| ---------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
6
{3}------------------------------------------------
പ്രവാഹ്യം
7
510(k) Summary, Continued
Differences
(
| Feature | Accu-Chek AdvantageMeter (predicate) | Accu-Chek Complete(new device) |
|---|---|---|
| Fail-safe Mechanisms | • Out of temperature range• Out of reporting range• Erroneous strip insert• Memory Checksum• Calibration code error• Low battery voltage | • Out of temperature range• Out of reporting range• Erroneous strip insert• Memory Checksum• Calibration code error• Low battery voltage• Serial CommunicationError Detector |
| Calculations other than bloodglucose test | None | Average, Minimum, andMaximum values for 2 days,7 days, 14 days, 30 days |
| Meter size | 91.4 x 50.8 x 15.2 mm | 120.50 x 71.98 x 25.98 mm |
| Display viewing size | 40.6 x 35.6 mm | 52 x 34.7 mm |
| Weight | 3 oz. with batteries | 3.5 oz. without batteries |
| Power supply | Two 3-volt lithium coin cellbatteries | Two AAA alkaline batteries |
| Data display | Numeric/Icon | Numeric/Icon/Graph |
| bG data stored in memory | mg/dl | mg/dl or mmol/l |
| Type of non-bG data stored | None | Carbohydrates, insulin,HbA1c, ketones, otherindices |
| Memory capacity | 100 blood glucose resultswith time and date | 1000 data records |
| Data port | Multiplexed TTL UART | RS232 |
| Buttons | 2 "ON/OFF" and "MEM" | 3 - multiple functioncorresponding to screendisplay |
| Turn On | Press "ON/OFF" button | Press any button or inserttest strip |
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services USA. The seal is circular, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter of the circle. Inside the circle is an abstract image of an eagle with its wings spread.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
DFC 1 5 1997
Mike Flis Requlatory Affairs Specialist Boehringer Mannheim 9115 Haque Road P.O. Box 50457 Indianapolis, Indiana 46250-0457
Re : K973662 Accu-Chek® Complete™ System Requlatory Class: II Product Code: LFR, CGA Dated: October 23, 1997 Received: October 24, 1997
Dear Mr. Flis:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note:
this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
{5}------------------------------------------------
Paqe 2
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770) 488-7655.
This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.qov/cdrh/dsmamain.html".
Sincerely yours,
Steven Litman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radioloqical Health
Enclosure
{6}------------------------------------------------
973662
510(k) Number (if known): 310(K) Name: Accu-Chek Complete System Indications for Use:
The Accu-Chek Complete System is intended for testing glucose by persons with diabetes or by health care professionals in the home or in health care facilities.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Clinical Laboratory Devices
510(k) Number 773667
Prescription Use (Per 21 CFR 801.109)
OR
Image /page/6/Picture/9 description: The image shows the text "Over-The-Counter Use" with a check mark next to it. The text is written in a simple, sans-serif font and is left-aligned. The check mark is drawn with a thick line and is positioned to the right of the text, indicating that the option has been selected.
(Optional Format 1-2-96)
§ 862.1345 Glucose test system.
(a)
Identification. A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.(b)
Classification. Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.